Newsfeeds Archive - Spark Newswire

4 minute read

SCYNEXIS Presented Preclinical Data On Second Generation Fungerp SCY-247 At The Congress Of The European Society Of Clinical Microbiology And Infectious Diseases

April 30, 4:39 PM

In vivo data demonstrated efficacy of SCY-247 in mouse model of invasive candidiasis caused by Candida glabrata SCY-247 showed in vitro activity against a broad range of pathogenic fungi, including azole-resistant

SCYX

1 minute read

News

5 Value Stocks To Watch In The Healthcare Sector

By Benzinga Insights

January 29, 10:44 AM

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the…

CALC

1 minute read

News

A Look Into Healthcare Sector Value Stocks

By Benzinga Insights

January 8, 10:44 AM

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the…

CYH

1 minute read

SCYNEXIS To Present Preclinical Data On Second Generation Fungerp SCY-247 At The 11th Advances Against Aspergillosis And Mucormycosis Conference, January 25 – 27, in Milan, Italy

By Benzinga Newsdesk

January 5, 9:36 AM

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of preclinical efficacy

SCYX

3 minute read

Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

January 4, 8:59 AM

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.

ABVC

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

January 3, 9:05 AM

Gainers NexImmune (NASDAQ:NEXI) stock increased by 84.4% to $4.38 during Wednesday’s pre-market session. The market value of their…

ABVC

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

January 2, 5:31 PM

Gainers First Wave BioPharma (NASDAQ:FWBI) shares increased by 40.8% to $5.38 during Tuesday’s after-market session. The company’s market…

AGRX

1 minute read

SCYNEXIS To Present Preclinical Data On Second Generation Fungerp SCY-247 At The 11th Congress On Trends In Medical Mycology October 20-23 In Athens, Greece

By Benzinga Newsdesk

October 16, 8:27 AM

SCYX

3 minute read

Gold Moves Lower; TransCode Therapeutics Shares Surge

By Lisa Levin

September 25, 2:43 PM

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to 13,243.56. The S&P 500 also rose, gaining, 0.19% to 4,328.30.

BCLI